
Arena Blog
Data-driven insights on trading strategies, backtests, and market analysis.
49–60 of 89 posts · page 5 of 8
Why your Sharpe ratio lies — and how we correct for it
Every additional backtest run increases the chance of finding good results by luck. The Deflated Sharpe Ratio (DSR) corrects for exactly this: it measures whether your result is real — or the best noise from N trials. Pro+ feature.
SQN, Expectancy, Profit Factor — the new backtest result panel
Win rate alone says little. The new Details tab shows four metrics serious backtester care about: SQN, Expectancy, Profit Factor, and a monthly/yearly breakdown of every trade.
Nobody Sees the Future — Why No AI Trading Tool Can Beat the Market
LLMs don't trade profitably. But why would anyone expect them to? The honest answer is uncomfortable: nobody can see the future, and markets are explicitly the opposite of a forecasting machine — they're a mechanism for the ongoing negotiation of disagreement. On the Grossman-Stiglitz paradox, why one side of every trade is convinced it's smarter than the other, and why AI trading tools mathematically neutralize themselves the moment they become widespread.
MACD Cross is live — two modes from one classic
A new strategy is live: Gerald Appel's MACD from the 1970s, now fully tunable (default 12/26/9). Two trade modes — classic signal cross or histogram flip — give you a reactive and a confirming variant from one indicator.
Bollinger Bands + RSI is live — the strict mean-reversion play
A new strategy is live: BB+RSI combines two classics into a strict mean-reversion setup. BUY only when price is at the lower Bollinger band AND RSI is oversold — two conditions, fewer false signals. Pro+.
EMA Cross is live — the configurable cousin of Golden Cross
A new strategy is live: two configurable EMAs cross — BUY on the upward cross, SELL on the downward cross. Default 9/21, faster and more tunable than Golden Cross. Plus optional volume- or price-confirmation filter to fight whipsaws.
New strategy: Take-Profit / Re-Entry — lock in gains, buy the dip
The Take-Profit / Re-Entry strategy combines two simple rules: sell when your target gain is reached, re-enter when price drops enough from the post-sell high. No indicator noise — just price and two parameters.
Grid trading bots, honestly evaluated — what "consistent profits" leaves out
Grid bots are marketed as "low-risk" and, with AI, as a source of "consistent profits." We checked the claims against the mechanics: a grid earns on sideways oscillation, not trends — and "always trading" means trend-chasing. A fair breakdown, plus how to actually evaluate a grid bot.
Funding Rates as a BTC Signal: We Tested It. It Doesn't Work The Way You Would Think
High funding rates signal overheated longs — a warning. Negative funding means shorts capitulating — a buy signal. The logic seems solid. We tested it across 6.7 years of BTC data. The results were the opposite of what we expected.
Bollinger Bands Squeeze is live — when the bands get tight
A new strategy is live: John Bollinger's classic volatility-cycle play. Wait for the bands to squeeze tight, then ride the long breakout above the upper band. Default 20/2.0/0.1. Pro+.
Look-Ahead-Bias — The Most Common Mistake in Self-Built Backtests, and Why 200% Returns Usually Lie
Most traders writing their own backtests accidentally look into the future. The result: spectacular backtests, collapsing live performance. A look at the subtlest methodology mistake in systematic trading — from the common `shift(-N)` to the innocuous `.mean()` aggregation without rolling window — and why we manually check every Backtesting Arena strategy for bias before release.
How to Backtest Token Unlocks: FDV, Dilution & the Hyperliquid Lesson
A buy signal fires — but the unlock calendar says a large tranche of supply hits the market in nine days. Do you take the trade? Using Hyperliquid and the FDV debate as the case: what the FDV-to-market-cap ratio really means, what token unlocks empirically do to price — and the one point-in-time trap that quietly makes almost every retroactive test worthless.
Don't miss new blog posts
One short email per new post — strategies, backtests, market analysis. No spam, unsubscribe with one click anytime.
By subscribing you accept our privacy policy. We use Resend for delivery. Double opt-in confirmation required.